AI assistant
CONMED Corp — Director's Dealing 2013
Jun 4, 2013
31971_dirs_2013-06-04_6d9641ef-ba7a-420f-a3f3-5de723812b12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-01
Reporting Person: Jones Gregory Renard (Vice President-Corporate QA/RA)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-01 | Common Stock | M | 750 | — | Acquired | 8243 | Direct |
| 2013-06-01 | Common Stock | F | 272 | $32.93 | Disposed | 7971 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 8771 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 8481 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 9281 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 8991 | Direct |
| 2013-06-01 | Common Stock | M | 560 | — | Acquired | 9551 | Direct |
| 2013-06-01 | Common Stock | F | 203 | $32.93 | Disposed | 9348 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 10148 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 9858 | Direct |
| 2013-06-01 | Common Stock | M | 800 | — | Acquired | 10658 | Direct |
| 2013-06-01 | Common Stock | F | 290 | $32.93 | Disposed | 10368 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 750 | Disposed | 2019-06-01 | Common Stock (750) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2019-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2020-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 560 | Disposed | 2020-06-01 | Common Stock (560) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2022-06-01 | Common Stock (800) | Direct |
| 2013-06-01 | Rsus (restricted Stock Units) | $0 | A | 4000 | Acquired | 2023-06-01 | Common Stock (4000) | Direct |
| 2013-06-01 | Sars (Stock Appreciation Rights) | $32.93 | A | 10000 | Acquired | 2023-06-01 | Common Stock (10000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan, with the RSUs vesting in equal amounts over a ten year period
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.